Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2Tomokazu Ohishi, Yukihiko Hara|PLoS ONE|2022Cited by 45
Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer TherapyTomokazu Ohishi, Manabu Kawada|Preprints.org|2025Cited by 0